MX2015009972A - Composition for binding aldehydes in the mouth. - Google Patents

Composition for binding aldehydes in the mouth.

Info

Publication number
MX2015009972A
MX2015009972A MX2015009972A MX2015009972A MX2015009972A MX 2015009972 A MX2015009972 A MX 2015009972A MX 2015009972 A MX2015009972 A MX 2015009972A MX 2015009972 A MX2015009972 A MX 2015009972A MX 2015009972 A MX2015009972 A MX 2015009972A
Authority
MX
Mexico
Prior art keywords
composition
cysteine
mouth
binding
toxic
Prior art date
Application number
MX2015009972A
Other languages
Spanish (es)
Inventor
Osmo Suovaniemi
Mikko Salaspuro
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Publication of MX2015009972A publication Critical patent/MX2015009972A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention concerns a non-toxic composition in the form of buccal tablets, sublingual tablets or lozenges, which comprises a combination of active agents including one or more aldehyde-binding cysteine compound(s) selected from the group of L-and D-cysteine, N-acetyl cysteine, and the pharmaceutically acceptable salts thereof,and xylitol, which composition further comprises one or more non-toxic additives that include one or more aromatic agents as well as one or more fillers or binders or both,and optional further additives.
MX2015009972A 2013-02-01 2014-01-31 Composition for binding aldehydes in the mouth. MX2015009972A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20135097A FI20135097L (en) 2013-02-01 2013-02-01 Composition for binding aldehydes in the mouth
PCT/FI2014/050076 WO2014118438A1 (en) 2013-02-01 2014-01-31 Composition for binding aldehydes in the mouth

Publications (1)

Publication Number Publication Date
MX2015009972A true MX2015009972A (en) 2016-03-11

Family

ID=51261516

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009972A MX2015009972A (en) 2013-02-01 2014-01-31 Composition for binding aldehydes in the mouth.

Country Status (6)

Country Link
EP (1) EP2950794A4 (en)
CN (2) CN108969500A (en)
EA (1) EA201591203A1 (en)
FI (1) FI20135097L (en)
MX (1) MX2015009972A (en)
WO (1) WO2014118438A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI127823B (en) * 2015-03-06 2019-03-15 Biohit Oyj Composition for preventing hangover symptoms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI121528B (en) * 2000-10-30 2010-12-31 Biohit Oyj Pharmaceutical composition to reduce the risk of sunk in cancer by binding acetaldehyde in saliva, stomach and colon
WO2006037848A1 (en) * 2004-10-08 2006-04-13 Biohit Oyj Method and preparation for binding aldehydes in saliva
FI122914B (en) * 2005-04-01 2012-08-31 Biohit Oyj Food composition for binding of acetaldehyde in the mouth and in the digestive tract and process for the preparation of the composition
FI20070705L (en) * 2007-09-14 2009-06-02 Biohit Oyj Binding of acetaldehyde in the mouth and in the stomach
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
FI20115377A (en) * 2011-04-18 2012-10-19 Biohit Oyj Medical products for use in conditions related to microbial infections of upper respiratory and digestive organs
FI20115680L (en) * 2011-06-29 2012-12-30 Biohit Oyj Liquid pharmaceutical compositions or combination products

Also Published As

Publication number Publication date
CN105307649A (en) 2016-02-03
EA201591203A1 (en) 2016-01-29
EP2950794A1 (en) 2015-12-09
FI20135097L (en) 2014-08-02
CN108969500A (en) 2018-12-11
WO2014118438A1 (en) 2014-08-07
EP2950794A4 (en) 2016-11-09

Similar Documents

Publication Publication Date Title
IN2014CN03506A (en)
MY148253A (en) Azaadamantane derivatives and methods of use
GEP20227397B (en) Inhibitors of influenza viruses replication
EA201171151A1 (en) CRYSTALLINE TRIPEPTIDE EPOXYKETON-PROTEASE INHIBITORS
TW200637810A (en) Substituted N-aminomethylenesulfonamides, their preparation and use as medicaments
MY164646A (en) Nicotine lozenge compositions
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
TW200744456A (en) Microbicidal composition
MX336279B (en) Microbicidal composition.
TN2012000392A1 (en) Oral formulations and lipophilic salts of methylnaltrexone
IN2015DN00885A (en)
MY156518A (en) Borinic compositions
EA201490761A1 (en) R (+) - N-Formylpropylglycinone
MY155410A (en) Compositions and devices
NI201300106A (en) ANTIHYPERTENSIVE PHARMACEUTICAL COMPOSITION
DK1971216T3 (en) CHEWING GUM CONTAINING STYRENE-DIEN BLOCK COPYLYMERS
MY149433A (en) Nutritional compositions containing punicalagins
MY153391A (en) Composition for controlling parasites on animals
MX2009008249A (en) Pharmaceutical composition comprising a campothecin derivative.
MX2010008668A (en) Fungicidal compositions comprising 3'-bromine-2,3,4,6'-tetrametho xy-2'-6-dimethylbenzophenone.
MX2014014609A (en) Composition for preventing headaches.
IN2012DN05142A (en)
MX2015009972A (en) Composition for binding aldehydes in the mouth.
MY161161A (en) Oral compositions
TR201000689A1 (en) Solid dosage forms containing cefprozil.